CHSN Chanson International Holding Annual reports only
Food and Kindred Products · Nasdaq · SEC CIK 1825349 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY0.2%
TTM net income YoY-75.2%
TTM EPS YoY-99.2%
Revenue 3-yr CAGR11.2%
Net income 3-yr CAGR—
Margins
Gross margin45.0%
Operating margin-10.3%
Net margin1.0%
FCF margin2.6%
EBITDA margin-5.5%
Returns
ROE0.5%
ROA0.3%
ROIC (approx.)-4.6%
Asset turnover0.30x
Leverage & solvency
Liabilities / assets31.4%
Debt / equity0.09x
Current ratio0.81x
Interest coverage-10.02x
Cash quality & payout
Operating cash flow / net income15.28x
Accruals ratio-4.3%
Payout ratio—
Capex / revenue13.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $18.27M | $18.23M |
| Cost of revenue | $10.05M | $11.03M |
| Gross profit | $8.22M | $7.19M |
| SG&A expense | $3.84M | $2.97M |
| Operating income | -$1.89M | -$529,620 |
| Interest expense | $188,327 | $50,928 |
| Pretax income | $261,695 | $830,889 |
| Income tax | $74,155 | $74,604 |
| Net income | $187,540 | $756,285 |
| EBITDA | -$997,403 | $294,249 |
| EPS (basic) | 0.03 | 3.68 |
| EPS (diluted) | 0.03 | 3.68 |
| Weighted avg. shares (diluted) | 5.37M | 205,296 |
| Balance sheet | ||
| Cash & equivalents | $8.64M | $12.10M |
| Receivables | $1.74M | $991,467 |
| Inventory | $830,597 | $738,773 |
| Current assets | $12.19M | $18.43M |
| PP&E, net | $7.06M | $4.44M |
| Intangibles | $226,250 | $262,500 |
| Total assets | $81.99M | $41.78M |
| Current liabilities | $15.11M | $14.14M |
| Short-term debt | $428,844 | $1.51M |
| Long-term debt | $4.65M | — |
| Total debt | $5.07M | — |
| Total liabilities | $25.77M | $23.35M |
| Shareholders' equity | $56.21M | $18.43M |
| Net debt | -$3.57M | — |
| Shares outstanding | 38.98M | 341,247 |
| Cash flow statement | ||
| Operating cash flow | $2.86M | $3.54M |
| Capital expenditure | $2.40M | $583,313 |
| Free cash flow | $468,593 | $2.95M |
| Investing cash flow | -$45.82M | $1.91M |
| Financing cash flow | $39.09M | $5.35M |
| Depreciation & amortization | $889,722 | $823,869 |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.